http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050078748-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2707056d594790a62947ee030653e6f8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B32-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B32-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3078
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D69-08
filingDate 2004-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b122e462dc149210be2c52043466dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_593a45890ffd7162ff4d6246bd00fb94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e029719f6e2eec9d911fed5cb649775d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cd1ce04ff5ca7e72b1176f63d3470f9
publicationDate 2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20050078748-A
titleOfInvention A blood compatible hollow fiber membrane, and a process of preparing for the same
abstract The present invention relates to a hollow fiber membrane having excellent blood compatibility and a method for producing the hollow fiber membrane of the present invention, characterized in that the hollow fiber membrane contains hyaluronic acid and its derivatives. In addition, the production method of the present invention is a spin dope consisting of a hydrophobic polymer, an organic solvent and a hydrophilic compound and the internal coagulation liquid is spun into the air with a double-tubular nozzle and then coagulated with an external coagulation liquid to produce hyaluronic acid in the spinning dope Tonic acid (Hyaluronic acid) and its derivatives are characterized by addition. The present invention can significantly reduce side effects such as blood coagulation when used as a blood purification hollow fiber membrane, in particular hemodialysis membrane is significantly superior blood compatibility compared to the conventional hollow fiber membrane.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2253370-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8771516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103055725-A
priorityDate 2004-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914

Total number of triples: 22.